Diag-Nose.io
PrivateLast Round
Seed
Jan 30, 2025
Total Funding Raised
$3.15M
Momentum Score
50 /100
Company Overview
Diag-Nose.io is a biotechnology company that provides an AI-powered precision medicine platform, RhinoMAP™, which uses proteomics and computational biology to analyze nasal samples for the diagnosis and treatment of chronic respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Medical Devices, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diag-Nose.io Comps
Public and private peers based on sector, stage, and business model.
Diag-Nose.io Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 30, 2025 |
Diag-Nose.io Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Radar Ventures | Seed |
| Specialty Physician Associates | Seed |
| Breakthrough Victoria | Seed |
Diag-Nose.io Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Diag-Nose.io's valuation, stock price, and market status.
